Ticker

6/recent/ticker-posts
Showing posts with the label FDAShow all
US FDA had inspected Aurobindo Pharma's Unit VII from May 2, 2022 to May 10, 2020 and had issued six observations.
USFDA closes warning letters for three sites of Dr Reddy's Laboratories | Pharma News
Dr Reddy's Labs Gets USFDA EIR For Srikakulam Formulations Plant  | Pharma News
USFDA clears four Indian manufacturing plants in 10 days | Pharma News
FDA encourages recovered patients to donate plasma for development of blood-related therapies | Pharma News
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis | Pharma News | FDA
USFDA retains OAI status for Indoco's Goa plant | Pharma News | FDA